Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 577

1.

Multivariate analyses reveal biological components related to neuronal signaling and immunity mediating EEG abnormalities in alcohol-dependent individuals from the COGA cohort.

Meda SA, Narayanan B, Chorlian D, Meyers JL, Gelernter J, Hesselbrock V, Bauer L, Calhoun VD, Porjesz B, Pearlson GD.

Alcohol Clin Exp Res. 2019 Apr 22. doi: 10.1111/acer.14063. [Epub ahead of print]

PMID:
31009096
2.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.

Franzmeier N, Rubinski A, Neitzel J, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2019 Apr 16;10(1):1766. doi: 10.1038/s41467-019-09564-5.

3.

A method for building a genome-connectome bipartite graph model.

Yu Q, Chen J, Du Y, Sui J, Damaraju E, Turner JA, van Erp TGM, Macciardi F, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Preda A, Vaidya J, Pearlson GD, Calhoun VD.

J Neurosci Methods. 2019 May 15;320:64-71. doi: 10.1016/j.jneumeth.2019.03.011. Epub 2019 Mar 19.

PMID:
30902651
4.

The spatial chronnectome reveals a dynamic interplay between functional segregation and integration.

Iraji A, Deramus TP, Lewis N, Yaesoubi M, Stephen JM, Erhardt E, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD.

Hum Brain Mapp. 2019 Mar 18. doi: 10.1002/hbm.24580. [Epub ahead of print]

PMID:
30884018
5.

A blood-based signature of cerebrospinal fluid Aβ1-42 status.

Goudey B, Fung BJ, Schieber C, Faux NG; Alzheimer’s Disease Metabolomics Consortium; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Mar 11;9(1):4163. doi: 10.1038/s41598-018-37149-7.

6.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.

Varatharajah Y, Ramanan VK, Iyer R, Vemuri P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 19;9(1):2235. doi: 10.1038/s41598-019-38793-3.

7.

Increased ventromedial prefrontal cortex activity and connectivity predict poor sertraline treatment outcome in late-life depression.

Emam H, Steffens DC, Pearlson GD, Wang L.

Int J Geriatr Psychiatry. 2019 May;34(5):730-737. doi: 10.1002/gps.5079. Epub 2019 Mar 11.

PMID:
30761621
8.

Predicting Alzheimer's disease progression using multi-modal deep learning approach.

Lee G, Nho K, Kang B, Sohn KA, Kim D; for Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 13;9(1):1952. doi: 10.1038/s41598-018-37769-z.

9.

Type 2 diabetes mellitus, brain atrophy, and cognitive decline.

Moran C, Beare R, Wang W, Callisaya M, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2019 Feb 19;92(8):e823-e830. doi: 10.1212/WNL.0000000000006955. Epub 2019 Jan 23.

PMID:
30674592
10.

Cognitive impairment from early to middle adulthood in patients with affective and nonaffective psychotic disorders.

Mollon J, Mathias SR, Knowles EEM, Rodrigue A, Koenis MMG, Pearlson GD, Reichenberg A, Barrett J, Denbow D, Aberizk K, Zatony M, Poldrack RA, Blangero J, Glahn DC.

Psychol Med. 2019 Jan 4:1-10. doi: 10.1017/S0033291718003938. [Epub ahead of print]

PMID:
30606277
11.

Functional connectivity predictors of acute depression treatment outcome.

Steffens DC, Wang L, Pearlson GD.

Int Psychogeriatr. 2019 Jan 3:1-5. doi: 10.1017/S1041610218002260. [Epub ahead of print]

PMID:
30602399
12.

Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Reininghaus U, Böhnke JR, Chavez-Baldini U, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga CA.

World Psychiatry. 2019 Feb;18(1):67-76. doi: 10.1002/wps.20607.

13.

Spatial dynamics within and between brain functional domains: A hierarchical approach to study time-varying brain function.

Iraji A, Fu Z, Damaraju E, DeRamus TP, Lewis N, Bustillo JR, Lenroot RK, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD.

Hum Brain Mapp. 2019 Apr 15;40(6):1969-1986. doi: 10.1002/hbm.24505. Epub 2018 Dec 26.

PMID:
30588687
14.

Contrasting contributions of anhedonia to obsessive-compulsive, hoarding, and post-traumatic stress disorders.

Pushkarskaya H, Sobowale K, Henick D, Tolin DF, Anticevic A, Pearlson GD, Levy I, Harpaz-Rotem I, Pittenger C.

J Psychiatr Res. 2019 Feb;109:202-213. doi: 10.1016/j.jpsychires.2018.11.029. Epub 2018 Dec 1.

PMID:
30572276
15.

Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, Lui S, Sweeney JA.

Schizophr Res. 2018 Dec;202:173-179. doi: 10.1016/j.schres.2018.07.003. Epub 2018 Jul 6.

PMID:
30539769
16.

Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Knowles EEM, Mathias SR, Pearlson GD, Barrett J, Mollon J, Denbow D, Aberzik K, Zatony M, Glahn DC.

Schizophr Res. 2018 Oct 26. pii: S0920-9964(18)30624-8. doi: 10.1016/j.schres.2018.10.022. [Epub ahead of print]

PMID:
30482645
17.

Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Clark VP, Mueller BA, de Zwarte SMC, Ophoff RA, van Haren NEM, Andreassen OA, Gurholt TP, Gruber O, Kraemer B, Richter A, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Catts S, Fullerton JM, Green MJ, Henskens F, Jablensky A, Mowry BJ, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Hong E, Kochunov P, Gur RE, Gur RC, Ford JM, Macciardi F, Mathalon DH, Potkin SG, Preda A, Fan F, Ehrlich S, King MD, De Haan L, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, Pomarol-Clotet E, Kelly S, Ciufolini S, Radua J, Murray R, Marques TR, Simmons A, Borgwardt S, Schönborn-Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Yun JY, Cannon DM, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, McIntosh AM, Whalley HC, Knöchel C, Oertel-Knöchel V, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2019 Apr 1;85(7):e35-e39. doi: 10.1016/j.biopsych.2018.10.003. Epub 2018 Nov 22. No abstract available.

PMID:
30470561
18.

How Music Impacts Visual Attention Training in Schizophrenia: A Pilot Study.

Shagan S, Shagan D, Shagan B, Fiszdon JM, Thime W, Haber LC, Pearlson GD, Choi J.

J Nerv Ment Dis. 2018 Dec;206(12):968-970. doi: 10.1097/NMD.0000000000000911.

PMID:
30439783
19.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2018 Nov 9. doi: 10.1007/s12035-018-1405-1. [Epub ahead of print]

PMID:
30414086
20.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Warren JD, Crutch S, Fox NC, Ourselin S, Schott JM, Rohrer JD, Alexander DC; Genetic FTD Initiative (GENFI); Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.

Supplemental Content

Loading ...
Support Center